ICAM1 and ovarian carcinoma: Groote et al. also demonstrated that ICAM-1 is expressed at low levels in ovarian carcinoma cells and that ICAM-1 overexpression reduces ovarian carcinoma A2780 cell growth in the absence of immune cells [25], which suggested that the immune microenvironment of tumors affects the function of ICAM-1.